Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Schaap

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Leukemia|March 21, 2003
Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphismsF Maas, N Schaap, S Kolen, et al.
Leukemia & Lymphoma|February 26, 1999
In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusionA Schattenberg, N Schaap, E Van De Wiel-Van Kemenade, et al.
Bone Marrow Transplantation|April 6, 2004
Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donorsA Schattenberg, A van der Meer, F Preijers, et al.
Leukemia|February 13, 2002
Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantationN Schaap, A Schattenberg, E Mensink, et al.
Bone Marrow Transplantation|March 24, 2015
The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIsL E Franssen, N W C J van de Donk, M E Emmelot, et al.
Bone Marrow Transplantation|April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMTT Czerw, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation|July 20, 2007
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusionH Levenga, R Woestenenk, A V Schattenberg, et al.
Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Bone Marrow Transplantation|June 6, 2017
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myelomaL E Franssen, M W H Roeven, W Hobo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Leukemia|March 21, 2003
Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphismsF Maas, N Schaap, S Kolen, et al.
Leukemia & Lymphoma|February 26, 1999
In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusionA Schattenberg, N Schaap, E Van De Wiel-Van Kemenade, et al.
Bone Marrow Transplantation|April 6, 2004
Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donorsA Schattenberg, A van der Meer, F Preijers, et al.
Leukemia|February 13, 2002
Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantationN Schaap, A Schattenberg, E Mensink, et al.
Bone Marrow Transplantation|March 24, 2015
The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIsL E Franssen, N W C J van de Donk, M E Emmelot, et al.
Bone Marrow Transplantation|April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMTT Czerw, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation|July 20, 2007
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusionH Levenga, R Woestenenk, A V Schattenberg, et al.
Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Bone Marrow Transplantation|June 6, 2017
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myelomaL E Franssen, M W H Roeven, W Hobo, et al.
Pageof 4